Paying user area
Try for free
Moderna Inc. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Analysis of Revenues
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Moderna Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
The financial data reveals a significant fluctuation in net income figures over the five-year period ending in 2023. Both reported and adjusted net incomes follow a closely similar trajectory, indicating consistent adjustments between reported figures and investment-related adjustments throughout these years.
- 2019 to 2020
- There was an increase in the net loss from 2019 to 2020, with reported net income declining from a negative 514 million US dollars to a negative 747 million US dollars. Adjusted net income shows a similar pattern, worsening slightly from negative 511 million to negative 746 million US dollars. This suggests a deepening of losses before the major recovery phase.
- 2020 to 2021
- A substantial turnaround occurred in 2021, with reported net income jumping dramatically to a positive 12,202 million US dollars, and adjusted net income almost mirroring this improvement at 12,159 million US dollars. This sharp increase indicates a major positive event or improvement in operations, possibly linked to successful commercialization or milestone achievements, as both reported and adjusted figures reflect a transformative positive impact.
- 2021 to 2022
- In 2022, net income levels declined from the peak of 2021 but remained strongly positive, with reported net income dropping to 8,362 million US dollars and adjusted net income slightly lower at 8,040 million US dollars. Despite the decrease, these figures demonstrate sustained profitability well above pre-2021 levels.
- 2022 to 2023
- The year 2023 saw a reversal back to losses, with reported net income falling to negative 4,714 million US dollars and adjusted net income close behind at negative 4,466 million US dollars. This return to negative results suggests significant challenges or one-time events impacting financial performance, eroding the profitability achieved in previous years.
Overall, the trend indicates a period of significant financial transformation characterized by deep losses in the earlier years, an exceptional peak in net income in 2021, followed by a moderate decline in 2022, and a subsequent return to net losses in 2023. The close alignment of reported and adjusted figures throughout the timeline suggests limited divergence between raw and adjusted performance measures, underscoring the consistency in the company's financial reporting relative to investment adjustments.
Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
The financial data over the five-year period displays substantial fluctuations in key profitability and efficiency ratios. Initially, the company experienced significant losses, as indicated by negative net profit margins, returns on equity (ROE), and returns on assets (ROA) in 2019 and 2020.
- Net Profit Margin
- The reported net profit margin improved markedly from a severe negative position of -373.77% in 2020 to a positive 69.04% in 2021, indicating a substantial turnaround in profitability. This margin then decreased to 45.36% in 2022, reflecting a reduction in profit relative to revenue, before reverting sharply to a negative figure of -70.66% in 2023. The adjusted net profit margin follows a similar pattern, which confirms the persistence of these trends even after accounting for investment adjustments.
- Return on Equity (ROE)
- The reported ROE mirrored the net profit margin's trajectory, moving from deeply negative territory (-43.75% in 2019 and -29.17% in 2020) to a peak of 86.26% in 2021, suggesting highly effective capital utilization and significant profitability that year. However, this reverted to 43.73% in 2022, signaling a decline, and then turned negative again in 2023 (-34.03%), indicating that the company incurred losses relative to shareholder equity. The adjusted ROE exhibits a comparable trend, confirming the robustness of these observations irrespective of adjustments.
- Return on Assets (ROA)
- Similar to ROE, the reported ROA was negative in the earlier years (-32.34% in 2019 and -10.18% in 2020), followed by a sharp upturn peaking at 49.46% in 2021, and then declining to 32.34% in 2022. The ratio again declined significantly to -25.58% in 2023, indicating losses relative to company assets. The adjusted ROA closely mirrors these figures, confirming the changing efficiency and profitability landscape over time.
Overall, the trends show a volatile financial performance. The company transitioned from heavy losses in 2019 and 2020 to strong profitability in 2021, with declining but still positive profitability in 2022, and then a return to loss making in 2023. The concurrent patterns in reported and adjusted figures suggest that these fluctuations are not primarily the result of extraordinary items or accounting adjustments, but rather reflect fundamental changes in business performance.
Moderna Inc., Profitability Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
2023 Calculations
1 Net profit margin = 100 × Net income (loss) ÷ Net product sales
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net income (loss) ÷ Net product sales
= 100 × ÷ =
The financial data reveals significant fluctuations in the company's profitability over the five-year period from 2019 to 2023. Both reported and adjusted net income figures exhibit a marked shift, with initial losses recorded in 2019 and 2020, followed by substantial profits in 2021 and 2022, before reverting to losses again in 2023.
- Reported Net Income (Loss)
- There was a loss of $514 million and $747 million in 2019 and 2020, respectively. This shifted dramatically in 2021 with a reported profit of $12,202 million, which then decreased to $8,362 million in 2022. The trend reversed in 2023, resulting in a reported loss of $4,714 million.
- Adjusted Net Income (Loss)
- Adjusted figures closely mirror reported net income, with losses of $511 million and $746 million in 2019 and 2020, respectively. Adjusted net income peaked at $12,159 million in 2021, declined to $8,040 million in 2022, and returned to a loss of $4,466 million in 2023.
- Reported Net Profit Margin
- The reported net profit margin reflects a similar pattern, showing a large negative margin in 2020 of approximately -373.77%. This improved significantly in 2021 and 2022, reaching 69.04% and 45.36%, respectively, indicating high profitability during these years. In 2023, the margin turned sharply negative, at -70.66%.
- Adjusted Net Profit Margin
- Adjusted margins are consistent with the reported margins, with a negative margin of approximately -373.17% in 2020, peak positive margins of 68.79% in 2021 and 43.61% in 2022, and a negative margin of -66.95% in 2023.
Overall, the data indicates a period of substantial earnings volatility. The company experienced heavy losses initially, then a pronounced improvement with high profitability in 2021 and 2022, followed by a significant decline resulting in losses in 2023. The adjusted figures closely track the reported outcomes, suggesting minimal impact from adjustments on the overall profitability trends. The sharp profit margins during 2021 and 2022 highlight a period of exceptional financial performance, while the return to negative margins in 2023 points to renewed financial challenges.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
2023 Calculations
1 ROE = 100 × Net income (loss) ÷ Stockholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net income (loss) ÷ Stockholders’ equity
= 100 × ÷ =
The financial data indicates considerable volatility in the net income figures over the observed periods. Initially, there were significant losses reported in the years ending December 31, 2019, and 2020, with net losses slightly widening from -514 million to -747 million US dollars. A dramatic turnaround occurred in 2021, where reported net income surged to 12,202 million, followed by a decline in 2022 to 8,362 million. However, the trend reversed again in 2023 with a return to a negative net income of -4,714 million US dollars.
The adjusted net income follows a similar pattern, demonstrating consistency between reported and adjusted figures. The losses in 2019 and 2020 were nearly identical to the reported figures at -511 million and -746 million, respectively. The adjusted net income spiked in 2021 to 12,159 million and then decreased to 8,040 million in 2022, followed by a return to losses at -4,466 million in 2023.
Return on equity (ROE) metrics reflect these income fluctuations clearly. Reported ROE was significantly negative in 2019 and 2020, at -43.75% and -29.17%, respectively, indicating substantial inefficiencies or losses relative to shareholder equity during those years. A strong positive ROE emerged in 2021 at 86.26%, illustrating highly profitable performance, followed by a reduction to 43.73% in 2022, still reflecting profitability but at a diminished level. In 2023, reported ROE turned markedly negative again at -34.03%, suggesting a return to unprofitable operations or equity erosion.
The adjusted ROE numbers closely mirror the reported ROE trends, confirming the reliability of the adjusted figures for performance assessment. Adjusted ROE was -43.49% and -29.12% in 2019 and 2020, respectively, peaking at 85.96% in 2021, then decreasing to 42.04% in 2022, and declining sharply to -32.24% in 2023.
Overall, the data depicts substantial earnings and profitability volatility, with a profound turnaround to strong positive financial performance in 2021 followed by significant reversals in subsequent years. This pattern suggests sensitivity to external or internal factors affecting profitability, necessitating careful monitoring of operational and market conditions going forward.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
2023 Calculations
1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net income (loss) ÷ Total assets
= 100 × ÷ =
The financial data reflects notable fluctuations in both reported and adjusted net income and their corresponding returns on assets (ROA) for the periods observed.
- Reported Net Income (Loss)
-
There is a marked progression from negative to positive territory between 2019 and 2021. The net loss of $514 million in 2019 escalated to a larger loss of $747 million in 2020, followed by a substantial net income of $12,202 million in 2021. This peak is succeeded by a decrease to $8,362 million in 2022 and a return to net loss of $4,714 million in 2023. The reversal from significant profitability in 2021 and 2022 to a loss in 2023 constitutes a key concern.
- Adjusted Net Income (Loss)
-
The adjusted net income figures closely mirror the reported net income trends, with an initial increase in losses from $511 million in 2019 to $746 million in 2020. Subsequently, the adjusted net income jumps sharply to $12,159 million in 2021. Thereafter, it decreases to $8,040 million in 2022 and turns negative again at $4,466 million in 2023. This alignment suggests that adjustments had minimal impact on the overall trend and confirm the volatile earnings trajectory.
- Reported Return on Assets (ROA)
-
The reported ROA follows a similar pattern to net income, beginning at -32.34% in 2019 and improving significantly to -10.18% in 2020. The ROA then surges dramatically to a highly positive 49.46% in 2021, before declining to 32.34% in 2022 and dropping below zero to -25.58% in 2023. This shift underscores the volatility in asset utilization effectiveness over the years reviewed.
- Adjusted Return on Assets (ROA)
-
Adjusted ROA closely tracks the reported ROA values, starting at -32.14% in 2019 and rising to -10.17% in 2020. The peak in 2021 is slightly lower at 49.29%, decreasing to 31.09% in 2022 and falling to -24.24% in 2023. The similarity between reported and adjusted ROA figures indicates that adjustments had little effect on the interpretation of asset performance trends.
Overall, the data presents a pattern of significant deterioration in profitability and asset returns in the early years (2019-2020), followed by substantial recovery and peak performance in 2021. The positive phase diminishes in 2022 and reverses sharply into losses by 2023. This cyclical behavior points to considerable earnings volatility and changing efficiency in asset utilization over the period under review.